Seed VC · New York
ExSight invests in early-stage companies developing breakthrough technologies to aid, diagnose, and treat large populations afflicted with vision diseases, leveraging deep ophthalmic domain expertise from accomplished retinal surgeons to efficiently analyze early-stage risk and drive superior returns.
Business models
biotech_therapeutics, hardware, deeptech_ip
Customer segments
Researchers, Hospitals, Clinicians
Geography
US
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Exsight Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Exsight Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
PlusCap
Climate Tech, Energy, Food and agritech
Seed VC
Ponooc
Climate Tech, Climate tech, transport
Seed VC
Pontifax Agtech
Climate Tech, Food and agritech
Seed VC
Positron Ventures
Climate Tech
Seed VC
Potential Climate Ventures
Climate Tech, Energy, Food and agritech
Seed VC
Powerhouse Ventures
Climate Tech, Energy, Transport and mobility
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Exsight Ventures is one of them, and we'll tell you exactly where they sit in your top 100.